Skip to content

Mark R. Boelkins, MD

NPI 1942396437ActiveIndividual· Internal Medicine, Nephrology· Grand Rapids, MI

Internal Medicine, Nephrology (MD) in Grand Rapids, Michigan, licensed in MI, with an NPI issued in October 2006. Part D covered 1,145 prescriptions written in 2024, 98% of them generic. Calliditas Therapeutics US Inc. reported $119.62 in payments in 2025, mostly food and beverage.

Overview

NPI1942396437
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedOct 4, 2006
Last updated in NPPESOct 29, 2021
Certified by providerOct 29, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Nephrology Primary207RN0300X4301047768MI

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nephrology (MI)

Part D prescriptions in 2024

Prescriptions (claims)1,145 · 2,328 30-day fills
Patients284
Total drug cost$98,302
Generic share98% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$119.62 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Calliditas Therapeutics US Inc.$119.621

What the 2025 payments were for

  • Food and Beverage$119.62 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nephrologists in Grand Rapids

All 25 nephrologists in Grand Rapids · All nephrologists in Michigan